Business Context and Reporting Period
This Form 6-K filing is dated June 6, 2005, submitted by Adherex Technologies Inc. (Note: The request metadata lists "Fennec Pharmaceuticals Inc.", but the filing text explicitly identifies the registrant as Adherex Technologies Inc.). The report serves to disclose the voting results from the Company's Annual and Special Meeting of Shareholders held on June 3, 2005, in compliance with Canadian National Instrument 51-102.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural disclosure regarding shareholder voting results and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document solely references the submission of voting results as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The only substantive action noted is the furnishing of shareholder voting results.
Investor Verification Checklist
- Verify the correct registrant name is Adherex Technologies Inc., not Fennec Pharmaceuticals Inc.
- Review Exhibit 99.1 (Voting Results) for specific details on shareholder resolutions passed on June 3, 2005.
- Confirm that no financial data is present in this specific Form 6-K and refer to the most recent Form 20-F for financial metrics.